Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 3Urinary Retention 2Urinary Bladder Neoplasms 1Recurrence 1Rectal Neoplasms 1Prostatic Hyperplasia 1Prostatic Diseases 1Lung Neoplasms 1Disease Progression 1

Interventions

Fluorouracil 267Oxaliplatin 266Capecitabine 224Leucovorin 209Irinotecan 151Radiotherapy 131Bevacizumab 112Cetuximab 81Folfox protocol 48Surgical Procedures, Operative 44Radiation 41Drug Therapy 41Neoadjuvant Therapy 40Chemoradiotherapy 33Chemotherapy, Adjuvant 32Panitumumab 27XELOX 25Magnetic Resonance Spectroscopy 22Radiotherapy, Intensity-Modulated 21Floxuridine 17Biopsy 16Nivolumab 15Gemcitabine 15Early Intervention, Educational 15pembrolizumab 14Laparoscopy 14IFL protocol 14Celecoxib 14trifluridine tipiracil drug combination 13Gene Expression Profiling 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Rectal Neoplasms × Tamsulosin × Clear all
NCT00606983 2011-07-20

Prevention of Acute Voiding Difficulty After Radical Proctectomy

Seoul National University Hospital

Phase 3 Completed
100 enrolled
Gastrointestinal

Rectal Neoplasms, Urinary Retention

Data powered by HemOnc (CC BY 4.0) Colophon âš¡